Provexis plc (AIM:PXS)
London · Delayed Price · Currency is GBP · Price in GBX 1.212
+0.072 (6.33%)
Jul 31, 2026, 2:11 PM GMT
Provexis Market Cap
Provexis has a market cap or net worth of 26.86 million as of July 31, 2026. Its market cap has increased by 53.69% in one year.
Market Cap
26.86M
Enterprise Value
25.80M
Revenue
871.27K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.21
ChartMarket Cap Chart
Since September 7, 2005, Provexis's market cap has increased from 2.24M to 26.86M, an increase of 1,097.93%. That is a compound annual growth rate of 12.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 26.86M | 27.22% |
| Dec 31, 2025 | 21.11M | 33.33% |
| Dec 31, 2024 | 15.83M | 9.84% |
| Dec 29, 2023 | 14.42M | -10.34% |
| Dec 30, 2022 | 16.08M | -6.76% |
| Dec 31, 2021 | 17.24M | -2.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haleon | 32.47B |
| Hikma Pharmaceuticals | 3.35B |
| HUTCHMED (China) | 1.44B |
| Allergy Therapeutics | 344.49M |
| Animalcare Group | 231.30M |
| Venture Life Group | 84.91M |
| ECO Animal Health Group | 65.73M |
| Shield Therapeutics | 47.01M |